ArticleLa Radiologia medica2026
Endovascular treatment of traumatic thoracic aortic injuries in patients with normal anatomy and anatomical variants: safety, efficacy and long-term follow-up.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Emergency endovascular repair of blunt thoracic aortic injury-related pseudoaneurysm using a castor single-branched stent graft: a case report and literature review.Frontiers in cardiovascular medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo evaluate the safety and the efficacy of thoracic endovascular aortic repair (TEVAR) in patients with traumatic thoracic aortic injuries (TTAIs), analyzing the mid-long-term outcomes. MATERIALS AND
methodsIn this retrospective and monocentric study, 20 patients (46 ± 17.0 years old; mean ± SD) underwent TEVAR for TTAI from February 2012 to April 2023. All patients were subjected to computed tomography angiography (CTA) before discharge; afterward, the follow-up was set up by CTA or magnetic resonance imaging (MRI). Technical success, clinical success, safety, and mid-long-term follow-up were evaluated.
resultsBoth technical and clinical success were 100%. No procedure-related death was reported. Safety was 95%. In four (20%) patients the left subclavian artery (LSA) was covered; in one out of these four (25%), revascularization was necessary through carotid-subclavian bypass. In a patient with an anatomic variant of aberrant right subclavian artery (ARSA) a stent placement was required. The follow-up's median duration was 17 ± 79.5 months (median ± IQR) and in three cases there were minimal complications: a stable type IA endoleak (EL) < 1 cm, a minimal irregularity of device's links, and a millimeter bird beak sign.
conclusionsTEVAR for TTAI was found to be safe (3 minimal complications) and effective both in the short and mid-long term. Patients' adherence to follow-up and contrast-induced kidney damage remains a challenge, but the use of MRI may be a valid alternative, avoiding ionizing radiation and the use of iodinated contrast media.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.